Zambam MÁ, Alves MA, Faraco DL, Musskopf MI

Idioma: Ingles.
Referencias bibliográficas: 24
Paginas: 810-814
Archivo PDF: 90.68 Kb.

RESUMEN

sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, Mele MR, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003; 52: 1200-5.

2. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008; 48: S68-S92.

3. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines Committe of the American Association for the Study of Liver Diseases, the Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-38.

4. De Franchis R, Baveno V Faculty. Revising Consensus in Portal Hypertension: Report of the Baveno V Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-8.

5. Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol 2006; 22: 254-62.

6. Berzigotti A, Gilabert R, Abraldes JG, Nicolau C, Bru C, Bosch J, García-Pagan JC. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am J Gastroenterol 2008; 103: 1159-67.

7. Burton JR, Liangpunsakul S, Lapidus J, Giannini E, Chalasani N, Zaman A. Validation of a multivariate model predicting presence and size of varices. J Clin Gastroeneterol 2007; 41: 609-15.

8. De Franchis R, Dell’Era A. Diagnosis and therapy of esophageal vascular disorders. Curr Opin Gastroenterol 2007; 23: 422-7.

9. De Franchis R. Noninvasive diagnosis of esophageal varices: is it feasible? Am J Gastroenterol 2006; 101: 2520-2.

10. Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis 2003; 35: 473-8.

11. Giannini EG, Botta F, Borro P, Dulbecco P, Testa E, Mansi C, Savarino V, et al. Application of the platelet count/ spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up. Dig Liver Dis 2005; 37: 779-85.

12. Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, Sohaey R, et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol 2006; 101: 2511-9.

13. Barrera F, Riquelme A, Soza A, Contreras A, Barrios G, Padilla O, Viviani P, et al. Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients. Ann Hepatol 2009; 8: 325-30.

14. Mattos AZ, Mattos AA, Vianna FF, Musskopf MI, Pereira- Lima JC, Maciel AC. Platelet count/spleen diameter ratio: analysis of its capacity as a predictor of the existence of esophageal varices. Arq Gastroenterol 2010; 47: 275-8.

15. Chawla S, Katz A, Attar BM, Gupta A, Sandhu DS, Agarwal R. Platelet count/spleen diameter ratio to predict the presence of esophageal varices in patients with cirrhosis: a systematic review. Eur J Gastroenterol Hepatol 2012; 24: 431-6.

16. Ying L, Lin X, Xie ZL, Hu YP, Shi KQ. Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis. Dig Dis Sci 2012; 57: 1672-81.

17. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003: 38: 518-26.

18. Passaia A Jr, Borderie D, Bernard D, Scatton O, Calmus Y, Conti F. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology. Transplant Proc 2009; 41: 679-81.

19. Castéra L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, Couzigou P, et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009; 50: 59-68.

20. Testa R, Testa E, Giannini E, Borro P, Milazzo S, Isola L, Ceppa P, et al. Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index. J Intern Med 2006; 260: 142-50.

21. Stefanescu H, Grigorescu M, Lupsor M, Maniu A, Crisan D, Procopet B, Feier D, et al. A new and simple algorithm for the noninvasive assessment of esophageal varices in cirrhotic patients using serum fibrosis markers and transient elastography. J Gastrointestin Liver Dis 2011; 20: 57-64.

22. Wang JH, Chuah SK, Lu SN, Hung CH, Chen CH, Kee KM, Chang KC, et al. Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus-related cirrhosis. J Gastroenterol Hepatol 2012; 27: 1213-8.

23. Sanyal AJ, Fontana RJ, Di Bisceglie AM, Everhart JE, Doherty MC, Everson GT, Donovan JA, et al. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc 2006; 64: 855-64.

24. Tafarel JR, Tolentino LHL, Correa LM, Bonilha DR, Piauilino P, Martins FP, Rodrigues RA, et al. Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers. Eur J Gastroenterol Hepatol 2011; 23: 754-8.